4,700 cancer providers can now order Abbott tests in their records system

robot
Abstract generation in progress

Abbott and Flatiron Health have integrated Abbott’s Precision Oncology portfolio into Flatiron’s OncoEMR platform, allowing 4,700 providers at over 1,600 community cancer centers to order Abbott tests and receive results directly within their clinical workflow. This integration is designed to streamline the process, reduce administrative burden, and accelerate informed treatment decisions for cancer patients. The available tests include Oncotype DX Breast Recurrence Score®, OncoExTra®, Oncodetect®, and Riskguard®, aiming to provide a unified experience for clinicians.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin